COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study

OBJECTIVE: To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for patients with moderate and severe COVID-19 disease. METHODS: This non-randomized prospective cohort study was conducted from May 21 to June 30, 2020, at four major tertiary hospitals in Kuwait. CCP was administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsharidah, Sondas, Ayed, Mariam, Ameen, Reem M., Alhuraish, Fatma, Rouheldeen, Najat A., Alshammari, Farah R., Embaireeg, Alia, Almelahi, Mariam, Adel, Maitham, Dawoud, Mohammed E., Aljasmi, Mohammad A., Alshammari, Nashmi, Alsaeedi, Abdullah, Al-Adsani, Wasel, Arian, Hussan, Awad, Husain, Alenezi, Humoud A., Alzafiri, Azeez, Gouda, Enas F., Almehanna, Mohammad, Alqahtani, Salem, Alshammari, Abdulrahman, Askar, Medhat Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717772/
https://www.ncbi.nlm.nih.gov/pubmed/33285283
http://dx.doi.org/10.1016/j.ijid.2020.11.198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717772/
https://www.ncbi.nlm.nih.gov/pubmed/33285283
http://dx.doi.org/10.1016/j.ijid.2020.11.198

Ejemplares similares